| Phase 1/2 |
| NCT04637503 |
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma |
Neuroblastoma |
Not Yet Recruiting |
2026-09-01 |
| NCT07180927 |
DLL3 CAR-T Therapy Targeting Brain Tumors |
Glioblastoma of Cerebellum |
Not Yet Recruiting |
2026-09-01 |
| NCT03217617 |
SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection |
SCID, X-Linked |
Not Yet Recruiting |
2026-08-27 |
| NCT03271632 |
Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma |
Multiple Myeloma |
Not Yet Recruiting |
2026-08-27 |
| NCT06429150 |
Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma |
Multiple Myeloma |
Not Yet Recruiting |
2026-08-27 |
| NCT06435897 |
Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells |
Autoimmune Diseases |
Not Yet Recruiting |
2026-08-27 |
| NCT06739226 |
Combination Immunotherapy Targeting Melanoma |
Melanoma |
Not Yet Recruiting |
2026-08-27 |
| NCT07477600 |
cfMSC Stem Cell Therapy Targeting COPD |
Chronic Obstructive Pulmonary Disease (COPD) |
Not Yet Recruiting |
2026-08-27 |
| NCT07495956 |
cfMSC Therapy for Diabetes |
Type II Diabetes Mellitus |
Not Yet Recruiting |
2026-08-27 |
| NCT07501156 |
H3K27M-specific Immune Effector Cells Targeting DMG/DIPG |
Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma |
Not Yet Recruiting |
2026-08-27 |
| NCT03222674 |
Multi-CAR T Cell Therapy for Acute Myeloid Leukemia |
Acute Myeloid Leukemia |
Not Yet Recruiting |
2026-08-26 |
| NCT03356782 |
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting… |
Sarcoma |
Not Yet Recruiting |
2026-08-26 |
| NCT03356808 |
Antigen-specific T Cells Against Lung Cancer |
Lung Cancer |
Not Yet Recruiting |
2026-08-26 |
| NCT03614650 |
Immunotherapy Treating GI Cancer |
Cancer |
Not Yet Recruiting |
2026-08-26 |
| NCT04016129 |
CAR-T Immunotherapy Targeting CD19- ALL |
B-cell Leukemia |
Not Yet Recruiting |
2026-08-26 |
| NCT04033302 |
Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies |
T-cell Acute Lymphoblastic Leukemia |
Not Yet Recruiting |
2026-08-26 |
| NCT04429438 |
Multi-CAR-T Cells Targeting B Cell Lymphomas |
B Cell Lymphoma (BCL) |
Not Yet Recruiting |
2026-08-26 |
| NCT04429451 |
PSMA-specific CAR-T Cell Therapy |
PSMA Positive Tumors or Tumor Tissues |
Not Yet Recruiting |
2026-08-26 |
| NCT04430595 |
Multi-4SCAR-T Therapy Targeting Breast Cancer |
Breast Cancer |
Not Yet Recruiting |
2026-08-26 |
| NCT04432649 |
Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276 |
Solid Tumor |
Not Yet Recruiting |
2026-08-26 |
| NCT04433221 |
Combination Immunotherapy Targeting Sarcomas |
Sarcoma |
Not Yet Recruiting |
2026-08-26 |
| NCT05432882 |
CD19/22 Bi-specific CAR-T Cell Therapy |
B Cell Malignancies |
Not Yet Recruiting |
2026-08-26 |
| NCT05436496 |
CD19/70 Bi-specific CAR-T Cell Therapy |
B Cell Malignancies |
Not Yet Recruiting |
2026-08-26 |
| NCT05437315 |
GD2/PSMA Bi-specific CAR-T Cell Therapy |
Solid Tumor |
Not Yet Recruiting |
2026-08-26 |
| NCT05438368 |
GD2/CD70 Bi-specific CAR-T Cell Therapy |
Cancer Disease |
Not Yet Recruiting |
2026-08-26 |